Literature DB >> 14691617

Fracture risk following an osteoporotic fracture.

O Johnell1, J A Kanis, A Odén, I Sernbo, I Redlund-Johnell, C Petterson, C De Laet, B Jönsson.   

Abstract

The aim of this study was to examine the pattern of fracture risk following a prior fracture at the spine, shoulder or hip. We studied 1918 patients with fractures at these sites identified from the Department of Radiology in Malmo who were followed for 5 years. Poisson regression was used to compute fracture rates immediately after the initial fracture and at 5 years thereafter in men and women aged 60 or 80 years. Immediate fracture risk was higher than that of the general population, more markedly so at the age of 60 than at 80 years. At the age of 60 years, the risk of hip, forearm and spine fractures were significantly increased following a prior spine, hip or shoulder fracture in men. A similar pattern was seen in women, except that the increase in risk of forearm fracture following a spine or hip fracture was not statistically significant. The incidence of further fractures at the shoulder, spine or hip fell with time after the first fracture, a fall that was significant for all fractures after a shoulder fracture, hip fracture after a spine fracture, and hip and spine fractures after a hip fracture. We conclude that the risk of a subsequent fracture immediately after an osteoporotic fracture is highest immediately after the event. This provides a rationale for very early intervention immediately after fractures to avoid recurrent fractures.

Entities:  

Mesh:

Year:  2003        PMID: 14691617     DOI: 10.1007/s00198-003-1514-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  16 in total

1.  Long-term risk of osteoporotic fracture in Malmö.

Authors:  J A Kanis; O Johnell; A Oden; I Sembo; I Redlund-Johnell; A Dawson; C De Laet; B Jonsson
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

2.  Remembering fractures: fracture registration and proband recall in southern Sweden.

Authors:  B Jónsson; P Gärdsell; O Johnell; I Redlund-Johnell; I Sernbo
Journal:  J Epidemiol Community Health       Date:  1994-10       Impact factor: 3.710

3.  Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures.

Authors:  H Castel; D Y Bonneh; M Sherf; Y Liel
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

4.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

5.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

6.  Risk of new vertebral fracture in the year following a fracture.

Authors:  R Lindsay; S L Silverman; C Cooper; D A Hanley; I Barton; S B Broy; A Licata; L Benhamou; P Geusens; K Flowers; H Stracke; E Seeman
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

7.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

8.  Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study.

Authors:  R Hasserius; M K Karlsson; B E Nilsson; I Redlund-Johnell; O Johnell
Journal:  Osteoporos Int       Date:  2003-01       Impact factor: 4.507

9.  Prescribing by general practitioners after an osteoporotic fracture.

Authors:  D J Torgerson; P Dolan
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

10.  Does a fracture at one site predict later fractures at other sites? A British cohort study.

Authors:  T P van Staa; H G M Leufkens; C Cooper
Journal:  Osteoporos Int       Date:  2002-08       Impact factor: 4.507

View more
  150 in total

Review 1.  Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.

Authors:  T Saito; J M Sterbenz; S Malay; L Zhong; M P MacEachern; K C Chung
Journal:  Osteoporos Int       Date:  2017-08-02       Impact factor: 4.507

2.  Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system.

Authors:  A Shibli-Rahhal; M S Vaughan-Sarrazin; K Richardson; P Cram
Journal:  Osteoporos Int       Date:  2011-01-27       Impact factor: 4.507

3.  A poisson process model for hip fracture risk.

Authors:  Zvi Schechner; Gangming Luo; Jonathan J Kaufman; Robert S Siffert
Journal:  Med Biol Eng Comput       Date:  2010-06-04       Impact factor: 2.602

4.  Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study.

Authors:  M S Cooper; A J Palmer; M J Seibel
Journal:  Osteoporos Int       Date:  2011-09-28       Impact factor: 4.507

5.  Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women.

Authors:  A H Holmberg; O Johnell; P M Nilsson; J Nilsson; G Berglund; K Akesson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

Review 6.  The epidemiology of osteoporosis.

Authors:  Michael A Clynes; Nicholas C Harvey; Elizabeth M Curtis; Nicholas R Fuggle; Elaine M Dennison; Cyrus Cooper
Journal:  Br Med Bull       Date:  2020-05-15       Impact factor: 4.291

7.  Does a history of non-vertebral fracture identify women without osteoporosis for treatment?

Authors:  Kathryn M Ryder; Steven R Cummings; Lisa Palermo; Suzanne Satterfield; Douglas C Bauer; Adrianne C Feldstein; John T Schousboe; Ann V Schwartz; Kristine Ensrud
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

Review 8.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

9.  Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.

Authors:  Suzanne M Cadarette; Jeffrey N Katz; M Alan Brookhart; Til Stürmer; Margaret R Stedman; Daniel H Solomon
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

10.  Prior nonhip limb fracture predicts subsequent hip fracture in institutionalized elderly people.

Authors:  K Nakamura; S Takahashi; M Oyama; R Oshiki; R Kobayashi; T Saito; Y Yoshizawa; Y Tsuchiya
Journal:  Osteoporos Int       Date:  2009-09-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.